Ultimately, we prove evidence that MCT4 is a metabolic vulnerability for BC–CAF crosstalk and that miR-425-5p, by downregulating MCT4, modulates the protumorigenic contribution of CAFs to BC environment and metabolism. This evidence concerns the gene SLC16A3 and breast cancer.